WNDM Medical acquires remaining 50% stake in Cellerat

WNDM Medical acquires remaining 50% interest in Cellerat, from Catalyst Group

In exchange of 50% stake, WNDM issued 1,136,815 shares of its newly created Series F convertible preferred stock.

Following the closing of this transaction, Ron Nixon, Founder and Managing Partner of CGI, was elected to WNDM’s board.

Date: March 25, 2019

Source: Seeking Alpha